跳至主要内容
临床试验/NCT04420390
NCT04420390Unknown不适用

Low Dose Radiotherapy as Antinflammatory Treatment for COVID-19 Pneumonitis

Hospital San Carlos, Madrid2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
41
试验地点
2
主要终点
Radiological response

研究概览

简要总结

SARS-CoV-2 is causing an unprecedented stress on healthcare systems around the world, due to its high rate of infection and the high morbidity and mortality.

The COVID-19 infection triggers an inflammatory cascade with cytokine synthesis, prompting the immune response. Low dose radiotherapy (LD-RT) (≤ 100 cGy) induces an anti-inflammatory response, lowering levels of pro-inflammatory cytokines such as IL-1β or inhibit leukocyte recruitment. LD-RT has been used historically for the pneumonia treatment reporting a rapid clinical improvement (within the first week), as well as a reduced mortality (from around 30% to 10%). Considering these results, LD-RT can potentially afford a therapeutic benefit against SARS-CoV-2. The study purpose is to evaluate prospectively the safety and efficacy of LD-RT for SARS-CoV-2.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 60 years.
  • COVID19 + confirmed by PCR.
  • Thoracic imaging study (chest X-ray, chest CT or PET-CT), compatible with lung involvement.
  • Phase II or lung phase without any improvement with pharmacological treatment.
  • Phase III or hyper-inflammatory phase without any improvement with pharmacological treatment
  • Poor clinical and functional respiratory evolution: > 30 breaths / minute, SpO2 <93%, PaO2 / FiO2 <
  • D-dimer> 1000 ng / mL or rising, ferritin> 1000 ng / mL, PCR> 10 mg / dL or double than before.

排除标准

  • Severe comorbidities that could hamper the radiation treatment.

结局指标

主要结局

Radiological response

时间窗: 7 days after low dose radiation

Radiological results: Radiological worsening, improvement or without significant changes

次要结局

  • Adverse events(1 year)
  • SPO2 and PaO2/FiO2(7 days)
  • blood cell count(3 days after low dose radiation)
  • Remission of respiratory symptoms(up to 6 months)
  • Overall survival(1 month)
  • Ferritin value(3 days after low dose radiation)
  • Hospitalization(3 months)
  • C-reactive protein(3 days after low dose radiation)
  • D-dimer(3 days after low dose radiation)
  • LDH levels(3 days after low dose radiation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manuel Gonzalo Vázquez Masedo

MD, PhD

Hospital San Carlos, Madrid

研究点 (2)

Loading locations...

相似试验